The short answer
Gymnema sylvestre may affect glucose control, but added low-blood-sugar risk with dulaglutide has not been directly measured. Have the full regimen reviewed.
What this answer covers
Gymnema sylvestre extract; plant part, standardization and dose must be verified.
- Supplement or preparation
- Gymnema sylvestre
- Medication ingredient
- dulaglutide
What the original study can tell us
A small placebo-controlled study in people with impaired glucose tolerance found lower two-hour glucose and HbA1c in the Gymnema group. It did not study dulaglutide users or establish an added hypoglycemia rate.
Other diabetes medicines matter
Dulaglutide’s label particularly warns of increased hypoglycemia when it is used with insulin or insulin-releasing medicines. The whole regimen and your previous low readings matter more than assuming every glucose-lowering product acts identically.
Check the preparation
Check the botanical species and extract details. The name miracle fruit can be ambiguous; it does not establish that a product is the Gymnema preparation studied.
Keep the prescribed medicine plan
Continue the prescribed once-weekly injection plan. Tell the clinician about reduced eating, persistent vomiting or diarrhea and all other diabetes medicines. A supplement is not a reason to alter the injection dose yourself.
Watch for low blood sugar
Follow your existing glucose-monitoring and low-blood-sugar treatment plan. New sweating, shakiness, hunger or confusion warrants a glucose check when possible. Severe confusion, a seizure or inability to swallow safely needs emergency help.
Evidence and practical considerations
Side effects & toxicity
Conditional glucose-monitoring concern follows from supplement glycemic effects. Dulaglutide-specific added clinical hypoglycemia is unproven; insulin or insulin-secretagogue co-use changes baseline risk.
- Exact scope
- Gymnema sylvestre extract; plant part, standardization and dose must be verified. with Exact dulaglutide once-weekly subcutaneous solution injection. Exact RxNorm IN1551291; TRULICITY subcutaneous once-weekly product, not oral semaglutide or an oral nutrient. Dose-dependent gastric emptying and concomitant medicines matter.
- Medication form and route
- subcutaneous
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact-pair human trial found. Small preparation-specific glucose studies do not establish a safe dose, interaction rate, altered injection exposure or protective interval.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed dulaglutide.
Glucose-dependent effects, delayed gastric emptying and gastrointestinal adverse reactions; increased hypoglycemia risk with insulin or insulin secretagogues. Tested oral-drug absorption not affected to clinically relevant degree at 1.5 mg.
How this applies: Exact RxNorm IN1551291; TRULICITY subcutaneous once-weekly product, not oral semaglutide or an oral nutrient. Dose-dependent gastric emptying and concomitant medicines matter.
No universal supplement dose, interval, event rate or untested formulation equivalence.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Thirty adults with impaired glucose tolerance.
Two-hour glucose and HbA1c decreased in the Gymnema group.
How this applies: Only the named drug, preparation, route and measured endpoints apply.
Small selected population, no dulaglutide co-use or measured exact-pair hypoglycemia; botanical dose/preparation not universal.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: 268df9b565402cc3
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.